A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia. Read more about A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia.
Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations. Read more about Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations.
TA-TMA: state of the art for diagnosis and treatment. Read more about TA-TMA: state of the art for diagnosis and treatment.
A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry. Read more about A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry.
Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation. Read more about Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation.
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings. Read more about End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.
Paroxysmal cold hemoglobinuria successfully treated with complement inhibition. Read more about Paroxysmal cold hemoglobinuria successfully treated with complement inhibition.
Integrated phosphoproteomics and transcriptional classifiers reveal hidden RAS signaling dynamics in multiple myeloma. Read more about Integrated phosphoproteomics and transcriptional classifiers reveal hidden RAS signaling dynamics in multiple myeloma.
CAR T-cell therapy: is it prime time in myeloma? Read more about CAR T-cell therapy: is it prime time in myeloma?
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia. Read more about Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.
